Lupin rises on receiving USFDA approval for generic Vibra-Tabs Tablet

11 Sep 2017 Evaluate

Lupin is currently trading at Rs. 977.95, up by 9.80 points or 1.01% from its previous closing of Rs. 968.15 on the BSE.

The scrip opened at Rs. 974.80 and has touched a high and low of Rs. 982.65 and Rs. 969.00 respectively. So far 274906 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1590.00 on 09-Sep-2016 and a 52 week low of Rs. 920.00 on 21-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1006.00 and Rs. 961.15 respectively. The current market cap of the company is Rs. 44183.50 crore.

The promoters holding in the company stood at 46.70%, while Institutions and Non-Institutions held 40.66% and 12.63% respectively.

Lupin has received final approval for its Doxycycline Hyclate Tablet USP, 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Pfizer Inc.'s Vibra-Tabs 100 mg. Doxycycline Hyclate Tablet USP, 100 mg had US sales of $149.9 million as per IMS MAT June 2017.

Lupin’s Doxycycline Hyclate Tablet USP, 100 mg is the AB rated generic equivalent of Pfizer Inc.'s Vibra-Tabs, 100 mg. It is indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2114.10 33.75 (1.62%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×